Results: During the study period, it was observed that most of the women (63%) belonged to age group between 21 and 30 years. More common congenital abnormalities were anencephaly (21%), bilateral hydronephrosis (17%), hydrocephalous (11%) and ventriculomegaly (8%
Background: Ovarian tumour is a leading cause of morbidity and mortality. Objective: The purpose of the present study was to observe the socio-economic conditions of the ovarian tumour patients. Methodology: This was a cross sectional observational study and was carried out in the Department of Obstetrics and Gynaecology at Bangabandhu Sheikh Mujib Medical University (BSMMU) Hospital, Dhaka from July 2008 to December 2008. Patient admitted in the Obstetrics and Gynaecology ward in BSMMU hospital with diagnosis as ovarian tumour were selected as study population. Woman suffering from ovarian tumour who were diagnosed by history, clinical presentation, laboratory finding's and finally, confirmed by operative findings and histopathological report were included in this study. Result: Out of total 382 patients admitted with different gynaecological problem into BSMMU Hospital, 50 (13.09%) were diagnosed as ovarian tumour. Out of 50 patients maximum number of patients belonged to age group 21-30 years (32%). Mean age 38.2±7.31 years with a range 16 to 69. Among the 50 patients 4% of patents belonged to upper class, 56% middle class and 40% were to lower class. Out of total 50 cases 8% were unmarried and 92% were married, of whom 12% were nuliparous and 80% were parous. Conclusion: In conclusion the ovarian tumours are most commonly occurred in middle aged women in the middle income group. The parous women are most commonly suffering from ovarian tumour.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.